Submission for OMB Review; Comment Request, 74666-74667 [2012-30155]
Download as PDF
74666
Federal Register / Vol. 77, No. 242 / Monday, December 17, 2012 / Notices
alternatives. Scoping comment cards
will be provided at the Open House
portion of the meeting for those who
need to leave early but who wish to
make a comment for the record. At
approximately 8 p.m., HHS/CDC will
give a brief overview of the current
conditions and the planning and EIS
processes. Individuals staying for this
portion of the Scoping Meeting may
make verbal statements or use a Scoping
comment card. A stenographer will
record this portion of the Scoping
Meeting. An American Sign Language
Interpreter will be available at both
portions of the Scoping Meeting. The
agenda is subject to change without
notice. A transcript of the meeting and
all comments received at the meeting
will be posted to the public docket at
www.regulations.gov.
Roybal Campus Security Guidelines
The Edward R. Roybal Campus is the
headquarters of the U.S. Centers for
Disease Control and Prevention and is
located at 1600 Clifton Road NE.,
Atlanta, Georgia. The meeting is being
held in a Federal government building;
therefore, Federal security measures are
applicable.
In planning your arrival time, please
take into account the need to park and
clear security. All visitors must enter
the Roybal Campus through the
entrance on Clifton Road; the guard
force will direct visitors to the
designated parking area. Visitors must
present government issued photo
identification (e.g., a valid Federal
identification badge, state driver’s
license, state non-driver’s identification
card, or passport). Non-United States
citizens must present a valid passport,
visa, Permanent Resident Card, or other
type of work authorization document.
All persons entering the building must
pass through a metal detector. Visitors
will be issued a visitor’s ID badge at the
entrance to Building 19 and will be
escorted in groups of 5–10 persons to
the meeting room. All items brought to
HHS/CDC are subject to inspection.
Dated: December 11, 2012.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2012–30276 Filed 12–14–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Understanding the Dynamics of
Disconnection from Employment and
Assistance.
OMB No.: New Collection.
Description: The Office of Planning,
Research and Evaluation,
Administration for Children and
Families (ACF), U.S. Department of
Health and Human Services (HHS), is
proposing a data collection activity to
improve understanding of low-income
individuals and families who are
disconnected from employment and
from public assistance and particularly
those not receiving cash assistance
through the Temporary Assistance for
Needy Families (TANF) program. ACF
is proposing to use a discussion guide
to collect qualitative information. The
guide will be used to interview
respondents in order to learn about their
experiences with disconnection. Topics
will include recent employment and
reasons for not working; use of public
benefit programs and reasons for using
or not using specific benefits; their
financial circumstances and material
well-being including the stability and
sources of income, housing and living
arrangements; their coping strategies for
addressing their circumstances; and
their views on potential pathways to
improve their financial and material
well-being.
Information will be collected in two
sites with relatively high concentrations
of low-income families: Los Angeles,
California and Southeast Michigan.
Respondents will be sampled from two
existing longitudinal surveys in those
sites: The Best Start Los Angeles Pilot
Community Evaluation, currently led by
the Urban Institute’s Health Policy
Center and the Center for Healthier
Children, Families and Communities at
the University of California Los Angeles
(UCLA), and the Michigan Recession
and Recovery Study OIRTO, conducted
by the National Poverty Center of the
University of Michigan.
Respondents: Low-income women
who have resident children and who are
neither employed nor receiving TANF
or Supplemental Security Income (SSI)
for themselves. Women who are
currently employed or receiving TANF
may be included in the study if they
experienced at least six months of
unemployment in the past two years,
had a child Lid were unmarried during
the period of unemployment, and were
not receiving TANF at the time.
ANNUAL BURDEN ESTIMATES
Annual
number of
respondents
Instrument
srobinson on DSK4SPTVN1PROD with
Advertisement Script (LA) ..............................................................................
Telephone Recruitment script and Screener (LA) .........................................
Follow-up Telephone Script to Schedule Interview (LA) ...............................
Consent Form for Interviews (LA) .................................................................
Receipt of Payment Form (LA) ......................................................................
Consent Form for Linking Data (LA) .............................................................
Telephone Recruitment Script and Screener (MI) .........................................
Consent Form for Interviews (MI) ..................................................................
Conversation Guide (LA and MI) ...................................................................
Estimated Total Annual burden
hours: 182.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 370
VerDate Mar<15>2010
16:21 Dec 14, 2012
Jkt 229001
300
100
36
36
36
36
35
30
66
L’Enfant Promenade SW., Washington,
DC 20447, Attn: OPRE Reports
Clearance Officer. All requests should
be identified by the title of the
information collection. Email address:
OPREinfocollection@acf.hhs.gov.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
1
1
1
1
1
90
Average
burden hours
per response
0.1
0.25
0.05
0.2
0.03
0.08
0.25
0.2
1.5
Total annual
burden hours
30
25
2
7
1
3
9
6
99
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
E:\FR\FM\17DEN1.SGM
17DEN1
Federal Register / Vol. 77, No. 242 / Monday, December 17, 2012 / Notices
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Steven M. Hanmer,
OPRE Reports Clearance Officer.
[FR Doc. 2012–30155 Filed 12–14–12; 8:45 am]
BILLING CODE 4184–09–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–1203]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Information To
Accompany Humanitarian Device
Exemption Applications and Annual
Distribution Number Reporting
Requirements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
revision of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
information to accompany humanitarian
device exemption (HDE) applications
and the collection of information
regarding the annual distribution
number (ADN).
DATES: Submit either electronic or
written comments on the collection of
information by February 15, 2013.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
srobinson on DSK4SPTVN1PROD with
SUMMARY:
VerDate Mar<15>2010
16:21 Dec 14, 2012
Jkt 229001
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, Daniel.Gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed revision of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Information To Accompany
Humanitarian Device Exemption
Applications and Annual Distribution
Number Reporting Requirements
(formerly: Humanitarian Device
Exemption Holders, Institutional
Review Boards, Clinical Investigators
and FDA Staff Humanitarian Device
Exemption Regulation: Questions and
Answers)—(OMB Control Number
0910–0661)—Revision
Under section 520(m) (21 U.S.C.
360j(m)) of the Federal Food, Drug, and
Cosmetic Act (the FD&C Act), the FDA
is authorized to exempt a humanitarian
use device (HUD) from the effectiveness
requirements in sections 514 and 515 of
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
74667
the FD&C Act (21 U.S.C. 360d and 360e)
provided that the device: (1) Is used to
treat or diagnose a disease or condition
that affects fewer than 4,000 individuals
in the United States; (2) would not be
available to a person with such a disease
or condition unless the exemption is
granted, and there is no comparable
device, other than another HUD
approved under this exemption,
available to treat or diagnose the disease
or condition; (3) the device will not
expose patients to an unreasonable or
significant risk of illness or injury; and
(4) the probable benefit to health from
using the device outweighs the risk of
injury or illness from its use, taking into
account the probable risks and benefits
of currently available devices or
alternative forms of treatment.
HUDs approved under an HDE cannot
be sold for an amount that exceeds the
costs of research and development,
fabrication, and distribution of the
device (i.e., for profit), except in narrow
circumstances. Section 613 of the Food
and Drug Administration Safety and
Innovation Act (FDASIA) (Public Law
112–144), signed into law on July 9,
2012, amended section 520(m) of the
FD&C Act. Under section
520(m)(6)(A)(i) of the FD&C Act, as
amended by FDASIA, a HUD approved
under an HDE is eligible to be sold for
profit if the device meets the following
criteria:
• The device is intended for the
treatment or diagnosis of a disease or
condition that occurs in pediatric
patients or in a pediatric subpopulation,
and such device is labeled for use in
pediatric patients or in a pediatric
subpopulation in which the disease or
condition occurs; or
• The device is intended for the
treatment or diagnosis of a disease or
condition that does not occur in
pediatric patients or that occurs in
pediatric patients in such numbers that
the development of the device for such
patients is impossible, highly
impracticable, or unsafe.
Section 520(m)(6)(A)(ii) of the FD&C
Act, as amended by FDASIA, provides
that the Secretary of Health and Human
Services (the Secretary) will assign an
ADN for devices that meet the eligibility
criteria to be permitted to be sold for
profit. The ADN is defined as the
number of devices ‘‘reasonably needed
to treat, diagnose, or cure a population
of 4,000 individuals in the United
States,’’ and therefore shall be based on
the following information in a HDE
application: the number of devices
reasonably necessary to treat such
individuals.
E:\FR\FM\17DEN1.SGM
17DEN1
Agencies
[Federal Register Volume 77, Number 242 (Monday, December 17, 2012)]
[Notices]
[Pages 74666-74667]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30155]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: Understanding the Dynamics of Disconnection from Employment
and Assistance.
OMB No.: New Collection.
Description: The Office of Planning, Research and Evaluation,
Administration for Children and Families (ACF), U.S. Department of
Health and Human Services (HHS), is proposing a data collection
activity to improve understanding of low-income individuals and
families who are disconnected from employment and from public
assistance and particularly those not receiving cash assistance through
the Temporary Assistance for Needy Families (TANF) program. ACF is
proposing to use a discussion guide to collect qualitative information.
The guide will be used to interview respondents in order to learn about
their experiences with disconnection. Topics will include recent
employment and reasons for not working; use of public benefit programs
and reasons for using or not using specific benefits; their financial
circumstances and material well-being including the stability and
sources of income, housing and living arrangements; their coping
strategies for addressing their circumstances; and their views on
potential pathways to improve their financial and material well-being.
Information will be collected in two sites with relatively high
concentrations of low-income families: Los Angeles, California and
Southeast Michigan. Respondents will be sampled from two existing
longitudinal surveys in those sites: The Best Start Los Angeles Pilot
Community Evaluation, currently led by the Urban Institute's Health
Policy Center and the Center for Healthier Children, Families and
Communities at the University of California Los Angeles (UCLA), and the
Michigan Recession and Recovery Study OIRTO, conducted by the National
Poverty Center of the University of Michigan.
Respondents: Low-income women who have resident children and who
are neither employed nor receiving TANF or Supplemental Security Income
(SSI) for themselves. Women who are currently employed or receiving
TANF may be included in the study if they experienced at least six
months of unemployment in the past two years, had a child Lid were
unmarried during the period of unemployment, and were not receiving
TANF at the time.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Annual number responses per hours per Total annual
of respondents respondent response burden hours
----------------------------------------------------------------------------------------------------------------
Advertisement Script (LA)....................... 300 1 0.1 30
Telephone Recruitment script and Screener (LA).. 100 1 0.25 25
Follow-up Telephone Script to Schedule Interview 36 1 0.05 2
(LA)...........................................
Consent Form for Interviews (LA)................ 36 1 0.2 7
Receipt of Payment Form (LA).................... 36 1 0.03 1
Consent Form for Linking Data (LA).............. 36 1 0.08 3
Telephone Recruitment Script and Screener (MI).. 35 1 0.25 9
Consent Form for Interviews (MI)................ 30 1 0.2 6
Conversation Guide (LA and MI).................. 66 90 1.5 99
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual burden hours: 182.
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 370 L'Enfant Promenade
SW., Washington, DC 20447, Attn: OPRE Reports Clearance Officer. All
requests should be identified by the title of the information
collection. Email address: OPREinfocollection@acf.hhs.gov.
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register. Therefore, a comment is best
assured of having its full effect if OMB receives it
[[Page 74667]]
within 30 days of publication. Written comments and recommendations for
the proposed information collection should be sent directly to the
following: Office of Management and Budget, Paperwork Reduction
Project, Email: OIRA SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the
Administration for Children and Families.
Steven M. Hanmer,
OPRE Reports Clearance Officer.
[FR Doc. 2012-30155 Filed 12-14-12; 8:45 am]
BILLING CODE 4184-09-M